Product
Natural full human monoclonal antibody CBB 1
1 clinical trial
1 indication
Indication
Rabies Virus InfectionClinical trial
Multicenter, Randomized, Double-blind, Placebo / Positive Control Evaluation of the First Safety, Pharmacokinetic and Pharmacodynamic Phase I Clinical Trial of Rabies Monomab CBB 1 in Healthy PeopleStatus: Not yet recruiting, Estimated PCD: 2023-12-30